Apart from increasing expression of the death receptors of TRAIL, radiotherapy (a genotoxic agent) may sensitize cancer cells to TRAIL by activating diverse TNF-associated apoptotic pathways in tumor cells, such as caspase-8, p38, or nuclear factor-kappa B (99–101). The gene discussed is TNFSF10; the disease is neoplasm.